ERLEADA 240 mg/1
Apalutamide · TABLET, FILM COATED · Janssen Products, LP
Erleada (apalutamide) is an oral tablet used to treat certain types of prostate cancer by blocking male hormones that help cancer cells grow. It is taken by mouth as a prescription medication.
Key Facts
- Brand Name
- ERLEADA
- Generic Name
- Apalutamide
- NDC Code (Product)
59676-604- Manufacturer
- Janssen Products, LP
- Strength
- 240 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA210951
- Marketing Start
- 02/14/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is ERLEADA used for?
Erleada (apalutamide) is an oral tablet used to treat certain types of prostate cancer by blocking male hormones that help cancer cells grow. It is taken by mouth as a prescription medication.
Is ERLEADA a controlled substance?
ERLEADA is not classified as a controlled substance by the DEA.
What is the generic name for ERLEADA?
The generic name for ERLEADA is Apalutamide. There are no other listed brand versions of Apalutamide.
What is the NDC code for ERLEADA 240 mg/1?
The NDC (National Drug Code) for ERLEADA 240 mg/1 is 59676-604, listed by Janssen Products, LP.
Other ERLEADA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)